# Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

> **NCT00788164** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 75 (actual)

## Conditions studied

- Cervical Cancer
- Precancerous Condition
- HPV Disease
- Human Papilomavirus

## Interventions

- **BIOLOGICAL:** TA-HPV
- **BIOLOGICAL:** pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
- **DRUG:** imiquimod

## Key facts

- **NCT ID:** NCT00788164
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2023-08
- **Final completion:** 2023-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788164, "Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00788164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*